Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: Rate of onset and radius of diffusion

Dermatologic Surgery

Volumn 29, Issue 5, 2003, Pages 519-522

  Flynn, Timothy Corcoran ^a,b   Clark II, Robert E ^b   Carruthers, Alastair ^c   Carruthers, Jean ^c  

^a Cary Skin Center   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ADULT; ARTICLE; CAPILLARY RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DIFFUSION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DYSPHAGIA; ECCHYMOSIS; EDEMA; FACE MUSCLE; FACE WRINKLING; FEMALE; FOREHEAD; HUMAN; IMAGE ANALYSIS; INJECTION PAIN; MALE; MUSCLE CONTRACTURE; OUTCOMES RESEARCH; PHOTOGRAPHY; PRIORITY JOURNAL; PTOSIS; SIDE EFFECT; SKIN DISEASE; XEROSTOMIA;

ADULT; BIOLOGICAL TRANSPORT; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; DIFFUSION; FACIAL MUSCLES; FEMALE; FOREHEAD; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; SKIN AGING; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037948962     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2003.29124.x     Document Type: Article

References (19)

1. Setler P. The biochemistry of botulinum toxin type B. Neurology 2000;55(Suppl 5):22-8.
2. Price J, Farish S, Taylor H, O'Day J. Blepharospasm and hemifacial spasm: randomized trial to determine the most appropriate location for botulinum toxin injections. Ophthalmology 1997;104:865-8.
3. Jankovic J, Schwarz KS. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993;43:834-6.
4. Lew MF, Adornato BT, Duane DD, et al. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 1997;45:701-7.
5. Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-46.
6. Lew MF, Brashear A, Factor S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology 2000;55: S29-35.
7. Fagian S. BOTOX for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 1999;103:701-13.
8. Blitzer A, Brin MF, Keen MS, Aviv JE. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993;119:1018-23.
9. Wieder JM, Moy RL. Understanding botulinum toxin: Surgical anatomy of the frown, forehead, and periocular region. Dermatol Surg 1998;24:1172-4.
10. Benedetto A. The cosmetic uses of botulinum toxin type A. Int J Dermatol 1999;38:641-55.
11. Goodman G. Botulinum toxin for the correction of hyperkinetic facial lines. Australas J Dermatol 1998;39:158-63.
12. Ahn KY, Park MY, Park DH, Han DG. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 2000;105:778-84.
13. Guerrissi J, Sarkissian P. Local injection into mimetic muscles of botulinum toxin A for the treatment of facial lines. Ann Plast Surg 1997;39:447-53.
14. Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MF. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injection sites in.
15. Ramirez AL, Reeck J, Maas CS. Botulinum toxin type B (MyoBloc) in the management of hyperkinetic facial lines. Otolaryngol Head Neck Surg 2002;126:459-67.
16. Baumann L, Slezinger A, Bryde J, et al. A Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) for the Treatment of Crow's Feet Wrinkles [poster]. Paris: World congress of Dermatology, July, 2002.
17. Lowe NJ, Yamauchi PS, Lask GP, et al. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing. J Cosmet Laser Ther 2002;4:15-8.
18. Sadick NS. Botulinum toxin type B for glabellar wrinkles: a prospective open-label response study. Dermatol Surg 2002;28: 817-21.
19. Matarasso SL. Comparison of botulinum types A and B: a bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg 2003;29:7-13.